Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia

Overview of attention for article published in Biomarker Research, January 2023

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 1 X post from an account with 34 followers.

Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia https://t.co/D5aeQlNKq9

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.